These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 14689581)

  • 1. Fatty acid synthase: a metabolic oncogene in prostate cancer?
    Baron A; Migita T; Tang D; Loda M
    J Cell Biochem; 2004 Jan; 91(1):47-53. PubMed ID: 14689581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In support of fatty acid synthase (FAS) as a metabolic oncogene: extracellular acidosis acts in an epigenetic fashion activating FAS gene expression in cancer cells.
    Menendez JA; Decker JP; Lupu R
    J Cell Biochem; 2005 Jan; 94(1):1-4. PubMed ID: 15523670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
    Menendez JA; Vellon L; Oza BP; Lupu R
    J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model.
    Pflug BR; Pecher SM; Brink AW; Nelson JB; Foster BA
    Prostate; 2003 Nov; 57(3):245-54. PubMed ID: 14518031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.
    Rossi S; Graner E; Febbo P; Weinstein L; Bhattacharya N; Onody T; Bubley G; Balk S; Loda M
    Mol Cancer Res; 2003 Aug; 1(10):707-15. PubMed ID: 12939396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells.
    Menendez JA; Lupu R
    Arch Immunol Ther Exp (Warsz); 2004; 52(6):414-26. PubMed ID: 15577743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression.
    Pizer ES; Pflug BR; Bova GS; Han WF; Udan MS; Nelson JB
    Prostate; 2001 May; 47(2):102-10. PubMed ID: 11340632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.
    Zhou W; Han WF; Landree LE; Thupari JN; Pinn ML; Bililign T; Kim EK; Vadlamudi A; Medghalchi SM; El Meskini R; Ronnett GV; Townsend CA; Kuhajda FP
    Cancer Res; 2007 Apr; 67(7):2964-71. PubMed ID: 17409402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells.
    Menendez JA; Lupu R
    Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):346-57. PubMed ID: 16778562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fatty acid synthase and prostate cancer].
    Wang KF; Wu B
    Zhonghua Nan Ke Xue; 2008 Aug; 14(8):740-2. PubMed ID: 18817351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid synthase and cancer: new application of an old pathway.
    Kuhajda FP
    Cancer Res; 2006 Jun; 66(12):5977-80. PubMed ID: 16778164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells.
    Brusselmans K; De Schrijver E; Verhoeven G; Swinnen JV
    Cancer Res; 2005 Aug; 65(15):6719-25. PubMed ID: 16061653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Androgens and increased lipogenesis in prostate cancer. Cell biologic and clinical perspectives].
    Verhoeven G
    Verh K Acad Geneeskd Belg; 2002; 64(3):189-95; discussion 195-6. PubMed ID: 12238242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid synthase activity in tumor cells.
    Little JL; Kridel SJ
    Subcell Biochem; 2008; 49():169-94. PubMed ID: 18751912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride.
    Schmidt LJ; Ballman KV; Tindall DJ
    Prostate; 2007 Jul; 67(10):1111-20. PubMed ID: 17477363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.